GlassScriptPhysician profile
Ehesar Caffroni
NPI 1275932964
$5,938.27
in general payments reported to CMS, 2019-2025
9 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $242 · 2022: $170 · 2023: $885 · 2024: $4,437 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,701 · Food and Beverage: $1,790 · Education: $926 · Honoraria: $110.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,700.75 |
| Food and Beverage | $1,789.65 |
| Education | $926.04 |
| Honoraria | $109.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Thommen Medical USA, LLC | $3,108.59 | 2022-2024 | |
| Benco Dental Supply Co. | $893.86 | 2021-2024 | |
| Patterson Companies, INC. | $771.88 | 2024 | |
| Dentsply Sirona INC | $572.50 | 2024-2025 | Primescan Connect |
| Straumann USA LLC | $509.84 | 2021-2025 | |
| Zimvie INC. | $31.84 | 2025 | |
| Orapharma, A Division of Bausch Health US, LLC | $18.64 | 2021 | |
| Geistlich Pharma, North America, INC. | $18.00 | 2023 | Bio-Gide |
| Voco America INC. | $13.12 | 2023 | Quick Up |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ehesar Caffroni listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.